Brainsway (BWAY)
(Delayed Data from NSDQ)
$6.29 USD
-0.27 (-4.12%)
Updated May 31, 2024 04:00 PM ET
After-Market: $6.27 -0.02 (-0.32%) 7:58 PM ET
3-Hold of 5 3
C Value A Growth A Momentum A VGM
Brokerage Reports
0 items in cart
Brainsway Ltd. Sponsored ADR [BWAY]
Reports for Purchase
Showing records 21 - 26 ( 26 total )
Company: Brainsway Ltd. Sponsored ADR
Industry: Medical - Products
Deep TMS Impact in Smoking Cessation Highlighted; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Brainsway Ltd. Sponsored ADR
Industry: Medical - Products
Company: Brainsway Ltd. Sponsored ADR
Industry: Medical - Products
KOL Webinar Highlights OCD Therapy Value Creation Potential; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Brainsway Ltd. Sponsored ADR
Industry: Medical - Products
Deep TMS Regulatory Clearance in Anxious Depression; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Brainsway Ltd. Sponsored ADR
Industry: Medical - Products
Modest Top and Bottom-Line Beat for 2Q21; Adjusting PT to $14
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Brainsway Ltd. Sponsored ADR
Industry: Medical - Products
Tapped Into Transcranial Magnetic Stimulation; Initiating at Buy and $17 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R